ARCHIVES

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 9 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

NCI Division To Promote Funds To Promote Collaboration.

February 18, 2000

Michigan’s Zhang Wins “Protein Science Olympics”

January 14, 2011

Health Organizations: ACS Statement Supports funding of Research On Human Stem cells

December 17, 1999

Regulatory Agencies: Health Warnings Sought on Cigars

July 23, 1999

FDA News: Clinton Nominates Jane Henney For FDA Commissioner

June 26, 1998